The Banking and Strategy Initiative

Chillin' out till it needs to be funded

Tag Archives: Hepatitis C

A couple that made winners | Hedge Funds/ Funds Management 2011

Bloomberg TV helped me a lot picking out the Top 4% of fund managers as Daniel Yachtman on Hedge Funds and Jim kieffer, announced Morning star stockpicker of the year … Continue reading

January 10, 2012 · 1 Comment

Bristol Myers offers $2.5 bln for Inhibitex | Advantage Dealbook

This next Pharma deal happened in the first week of January 2012 itself as another maker of Hepatitis C drugs in Georgia recommended Bristol Myers’ $26 per share offer to … Continue reading

January 9, 2012

Advantage Dealbook: Upending that premium again, Gilead gets HCV portfolio

The culprit of course is another rrich Pharma company saturated with its current mdeicine/ device/service product opr package portfolio. After a J&J bid for Synthes that has ┬ánot progressed and … Continue reading

November 21, 2011 · 2 Comments